RhAPP

TYK2 inhibition is one of the hottest topics in rheumatology right now🔥

What do APPs need to know about the latest data in psoriatic arthritis, lupus, and Sjögren’s syndrome?

Tune in as Amanda Mixon, PA-C, Danielle Gatti-Palumbo, PharmD, and Jennifer Mylod, DNP, break down the science, clinical trials, and future of TYK2-targeted therapies.

Listen now: https://bit.ly/TYK2-Inhibition